+181.2%
MRNA vs GD
+54.8%
+126.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | -1.0% | -2.6% | -3.1% |
| 7D | -20.0% | -0.7% | -19.3% | -19.7% |
| 30D | -1.3% | +4.5% | -5.7% | -3.8% |
| 3M | +240.0% | -8.7% | +248.7% | +256.7% |
| 6M | +339.0% | +8.5% | +330.4% | +312.3% |
| YTD | +630.0% | +8.8% | +621.2% | +584.7% |
| 1Y | +769.1% | +6.4% | +762.7% | +728.4% |
| 3Y | +181.2% | +55.5% | +125.8% | +146.8% |
| All | +181.2% | +54.8% | +126.4% | +146.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GD.
Daily Out/Under-Performance
Portfolio return minus GD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling